Pull to refresh
Logo
Arcline buys AstroNova in all-cash take-private deal

Arcline buys AstroNova in all-cash take-private deal

Money Moves

A Rhode Island industrial-printing maker exits the stock market for $29 a share after an activist fight and a year of churn

June 17th, 2026: Arcline agrees to buy AstroNova

Overview

Updated Jun 18

AstroNova's stock traded under $10 in early April, after years of weak returns and a public fight with an activist investor. On June 17, the Rhode Island maker of aircraft printers and industrial labeling machines agreed to sell itself to Arcline Investment Management for $29 a share in cash.

The all-cash deal values AstroNova at about $272 million and will pull it off the Nasdaq stock market. For shareholders, the price is a 209% premium over where the stock closed the day before the company announced it was exploring a sale. The deal ends a turbulent year. A proxy fight, a CEO resignation, and a new chief executive all landed within months.

Why it matters

AstroNova shareholders get $29 a share in cash, nearly triple the stock's price before the company put itself up for sale.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$29.00
Cash price per share
What each AstroNova shareholder gets, paid in cash.
$272M
Total deal value
Approximate enterprise value of the all-cash acquisition.
209%
Premium to pre-review price
Markup over AstroNova's April 6 close, before the strategic review.
$9.65M
Termination fee
Reciprocal break fee if either side walks away from the deal.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

May 2025 June 2026

7 events Latest: June 17th, 2026 · 3 months ago
Tap a bar to jump to that date
  1. Arcline agrees to buy AstroNova

    Latest Deal

    AstroNova agrees to a $29-per-share all-cash sale to Arcline, valuing the company at about $272 million. The board approves it unanimously.

  2. AstroNova shares jump roughly 70% on the deal

    Market

    AstroNova stock surged about 70% after the announcement, closing near the $29 deal price as traders priced in the all-cash offer.

  3. Company puts itself up for review

    Corporate

    AstroNova announces a review of strategic alternatives, including a possible sale. The stock had closed near $9 the prior day.

  4. New CEO installed

    Leadership

    Jorik Ittmann becomes president and CEO. Darius Nevin shifts to executive chairman.

  5. Proxy contest goes to a vote

    Governance

    AstroNova holds its annual meeting, where shareholders vote on the activist's competing slate of directors.

  6. CEO resigns

    Leadership

    Greg Woods steps down as president and CEO. Darius Nevin takes over on an interim basis.

  7. Activist launches proxy fight

    Governance

    Askeladden Capital files a definitive proxy nominating five directors to AstroNova's board, citing years of poor returns.

Scenarios

1

Shareholders approve the sale and the deal closes on schedule

Likely Resolves by End of 2026

Discussed by: AstroNova and Arcline, in the deal announcement

With a 209% premium and a board behind it, the deal clears its shareholder vote and antitrust review without trouble. AstroNova delists from the Nasdaq and becomes a private Arcline company in the third quarter of 2026. This is the path both companies have laid out.

2

A rival bidder tops Arcline's offer

Unlikely Resolves by Q3 2026

Discussed by: Merger terms allowing the board to weigh superior proposals

The agreement bars AstroNova from shopping itself but lets the board consider an unsolicited better offer before the shareholder vote. Another buyer could emerge and force Arcline to raise its price or walk, paying the break fee. Given the size of the premium already on the table, a competing bid would be a surprise.

3

Antitrust or vote timing pushes the close past Q3 2026

Possible Resolves by Oct 15, 2026

Discussed by: Standard closing conditions in the merger agreement

The deal still needs clearance under the Hart-Scott-Rodino Act, the U.S. antitrust review law, plus a shareholder vote. Either step could slip, delaying a close past the targeted third quarter without killing the deal. The companies have flagged these as the main gates.

4

The deal collapses before closing

Unlikely Resolves by End of 2026

Discussed by: Reciprocal termination provisions in the agreement

A failed shareholder vote, a regulatory block, or a buyer's change of heart could end the agreement. Either side would owe a roughly $9.65 million break fee depending on the cause. With the board united and the premium high, a collapse looks improbable.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

2013

Michael Dell takes Dell private (2013)

Founder Michael Dell and Silver Lake offered about $24.9 billion, or $13.65 a share, to take Dell private. Activist Carl Icahn fought the price as too low and waged a months-long battle before shareholders approved a slightly sweetened deal.

Then

Dell left the public markets in late 2013 after a contentious vote.

Now

Dell returned to public trading in 2018, much larger after acquiring EMC.

Why this matters now

It shows how take-private deals can draw fights over price, the same risk AstroNova's offer faces before its shareholder vote.

2017-2019

Elliott pushes athenahealth into a buyout (2018)

Activist hedge fund Elliott Management took a stake in athenahealth, then made a public bid and pressed for a sale. The health-software maker ran a strategic review and agreed to a $5.7 billion take-private led by Veritas Capital and Elliott's own buyout arm.

Then

athenahealth's CEO departed and the company left the public markets in early 2019.

Now

It was later combined with another firm and resold to new private owners at a higher valuation in 2022.

Why this matters now

Like AstroNova, athenahealth faced activist pressure, replaced leadership, ran a review, and ended up sold to private equity.

2023

KKR wins a bidding war for CIRCOR (2023)

Private-equity firm KKR agreed to buy CIRCOR International, a maker of industrial flow-control equipment, then raised its offer twice to fend off a rival bidder. The final deal valued the company at roughly $1.8 billion.

Then

CIRCOR shareholders accepted the raised offer and the company went private.

Now

KKR folded CIRCOR into its industrials portfolio as a standalone platform.

Why this matters now

CIRCOR shows private equity paying up for niche industrial suppliers, the same logic behind Arcline's interest in AstroNova.

Sources

(10)